Spectral AI Inc. (MDAI) - Net Assets
Based on the latest financial reports, Spectral AI Inc. (MDAI) has net assets worth $-8.20 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.30 Million) and total liabilities ($23.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read MDAI total debt and obligations for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-8.20 Million |
| % of Total Assets | -53.61% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 26635.35 |
Spectral AI Inc. - Net Assets Trend (2020–2024)
This chart illustrates how Spectral AI Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore Spectral AI Inc. (MDAI) total assets for the complete picture of this company's asset base.
Annual Net Assets for Spectral AI Inc. (2020–2024)
The table below shows the annual net assets of Spectral AI Inc. from 2020 to 2024. For live valuation and market cap data, see Spectral AI Inc. (MDAI) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-7.25 Million | -324.28% |
| 2023-12-31 | $-1.71 Million | -114.25% |
| 2022-12-31 | $12.00 Million | -12.78% |
| 2021-12-31 | $13.75 Million | +56438.54% |
| 2020-12-31 | $24.32K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Spectral AI Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4810232500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.00K | % |
| Other Comprehensive Income | $3.00K | % |
| Other Components | $40.85 Million | % |
| Total Equity | $-7.25 Million | 100.00% |
Spectral AI Inc. Competitors by Market Cap
The table below lists competitors of Spectral AI Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Transcontinental Inc
TO:TCL-B
|
$47.59 Million |
|
H2APEX Group SCA
XETRA:H2A
|
$47.61 Million |
|
NIGHTINGALE HEALTH EO 1
F:7XE
|
$47.63 Million |
|
Feytech Holdings Berhad
KLSE:5322
|
$47.63 Million |
|
Yanaprima Hastapersada Tbk
JK:YPAS
|
$47.56 Million |
|
AWC Berhad
KLSE:7579
|
$47.48 Million |
|
Starcore International Mines Ltd
TO:SAM
|
$47.45 Million |
|
Homecast Co.Ltd
KQ:064240
|
$47.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Spectral AI Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,709,000 to -7,251,000, a change of -5,542,000.
- Net loss of 15,315,000 reduced equity.
- New share issuances of 4,060,000 increased equity.
- Other comprehensive income decreased equity by 9,000.
- Other factors increased equity by 5,722,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-15.31 Million | -211.21% |
| Share Issuances | $4.06 Million | +55.99% |
| Other Comprehensive Income | $-9.00K | -0.12% |
| Other Changes | $5.72 Million | +78.91% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Spectral AI Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.77 | $2.15 | x |
| 2022-12-31 | $0.67 | $2.15 | x |
| 2023-12-31 | $-0.12 | $2.15 | x |
| 2024-12-31 | $-0.40 | $2.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Spectral AI Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -51.77%
- • Asset Turnover: 2.45x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-13.32%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -29.00% | -26.17% | 0.82x | 1.35x | $-5.36 Million |
| 2022 | -24.27% | -11.48% | 1.36x | 1.56x | $-4.11 Million |
| 2023 | 0.00% | -115.50% | 1.69x | 0.00x | $-20.68 Million |
| 2024 | 0.00% | -51.77% | 2.45x | 0.00x | $-14.59 Million |
Industry Comparison
This section compares Spectral AI Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Spectral AI Inc. (MDAI) | $-8.20 Million | -29.00% | N/A | $47.57 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About Spectral AI Inc.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary predic… Read more